TERTIARY LYMPHOID STRUCTURES IN DEVELOPING INFLAMMATORY SCAR OF HYPOKALEMIC NEPHROPATHY

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/170651453b3f123b142b7581ee0cfc88.pdf
TERTIARY LYMPHOID STRUCTURES IN DEVELOPING INFLAMMATORY SCAR OF HYPOKALEMIC NEPHROPATHY

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Takanori
Komada
Takanori Komada t_komada@jichi.ac.jp Jichi Medical University Division of Inflammation Research, Center for Molecular Medicine Shimotsuke Japan *
Satoko Komori satoko.t@jichi.ac.jp Jichi Medical University Division of Inflammation Research, Center for Molecular Medicine Shimotsuke Japan -
Tadayoshi Karasawa tdys.karasawa@jichi.ac.jp Jichi Medical University Division of Inflammation Research, Center for Molecular Medicine Shimotsuke Japan -
Yoshiyuki Morishita ymori@jichi.ac.jp Jichi Medical University Division of Nephrology, Department of Internal Medicine Shimotsuke Japan -
Noriyoshi Fukushima nfukushima@jichi.ac.jp Jichi Medical University Department of Pathology Shimotsuke Japan -
Daisuke Nagata ngtdsktky@gmail.com Jichi Medical University Division of Nephrology, Department of Internal Medicine Shimotsuke Japan -
Masafumi Takahashi masafumi2@jichi.ac.jp Jichi Medical University Division of Inflammation Research, Center for Molecular Medicine Shimotsuke Japan -
-
-
-
-
-
-
-
-

Potassium (K+) is an essential ion that helps the cells/organs function properly. Systemic K+ deficiency occasionally leads to kidney dysfunction, inflammation, and injury, known as hypokalemic nephropathy (HN). A low-K+ microenvironment in the kidney triggers excessive immune activation, resulting in HN progression. To resolve this malnourished microenvironment, HN is commonly treated with K+ supplementation; however, the long-term prognosis of HN and the role of inflammation have not been thoroughly explored. 

Five human kidney biopsy samples of clinically diagnosed HN, sourced from the kidney biopsy database at Jichi Medical University Hospital from 1997 to 2022, were immunostained. Clinical data were followed in the medical records. 

Six-week-old C57BL6/J male mice were fed a low-K+ diet or standard chow for 6 weeks, followed by a recovery diet (standard chow) for 6 months. Blood and kidney samples were analyzed.

Five HN kidney biopsy samples of anorexia nervosa, Crohn’s disease, laxative abuse, Sjögren’s syndrome, and licorice overuse were immunostained. Macrophages (CD68) and T lymphocytes (CD3ε) were infiltrated in all samples. T lymphocyte aggregates were observed in HN kidneys with laxative abuse, Sjögren’s syndrome, and licorice overuse. Four in 5 HN patients were followed for a mean duration of 8.4±3.4 years. The change in eGFR was 1.3±2.7 mL/min/1.73m2/year, and no one progressed to end-stage kidney disease. 

In mouse experiments, K+ depletion induced by a six-week treatment of a low-K+ diet was sufficient to cause kidney dysfunction, tubular necrosis, inflammation, and fibrosis. A six-month recovery diet following a low-K+ diet effectively restored serum K+ and kidney function.  However, histological analysis displayed persistent tubular injury and fibrosis 6 months after recovery. Interstitial aggregates composed of T and B cells developed in the kidney 6 months after recovery from HN, suggesting tertiary lymphoid structure (TLS) de novo formation, which was not observed in age-matched controls or HN kidneys before K+ repletion.

Long-term prognosis of HN of various etiologies showed favorable kidney function. We identified TLS-like lymphocyte aggregates in human HN kidneys. TLSs developed in experimental post-HN kidneys of mice. This study suggests that TLSs may expand during or after the development of HN and serve as a perpetuating inflammatory microenvironment in the HN kidney.

Kewords